We are live on ! Find out more
ACHV icon

Achieve Life Sciences

56 hedge funds and large institutions have $20.3M invested in Achieve Life Sciences in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 6

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

8% more funds holding

Funds holding: 5256 (+4)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

16% less capital invested

Capital invested by funds: $24.1M → $20.3M (-$3.74M)

81% less call options, than puts

Call options by funds: $42K | Put options by funds: $220K

Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
1.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
16
Reduced
9
Closed
6
Calls
$42K
Puts
$220K
Net Calls
-$178K
Net Calls Change
+$107K
Name Holding Trade Value Shares
Change
Change in
Stake
TI
26
Telemetry Investments
New York
$114K +$112K +23 New
SIP
27
Stoneridge Investment Partners
Pennsylvania
$113K +$19.6K +4 +22%
Northern Trust
28
Northern Trust
Illinois
$110K
California Public Employees Retirement System
29
California Public Employees Retirement System
California
$102K
Susquehanna International Group
30
Susquehanna International Group
Pennsylvania
$99K -$68.4K -14 -41%
Deutsche Bank
31
Deutsche Bank
Germany
$88K +$88K +18 New
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$85K
Two Sigma Advisers
33
Two Sigma Advisers
New York
$84K +$83.1K +17 New
RFC
34
Russell Frank Company
Washington
$71K -$58.7K -12 -46%
CAM
35
ClariVest Asset Management
California
$63K +$63.5K +13 New
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$56K +$14.7K +3 +38%
Millennium Management
37
Millennium Management
New York
$50K -$29.3K -6 -38%
Bank of America
38
Bank of America
North Carolina
$49K
VKH
39
Virtu KCG Holdings
New York
$47K +$14.7K +3 +50%
RCM
40
Rotella Capital Management
Washington
$45K +$44K +9 New
KeyBank National Association
41
KeyBank National Association
Ohio
$42K
Bank of New York Mellon
42
Bank of New York Mellon
New York
$39K
Group One Trading
43
Group One Trading
Illinois
$37K +$4.89K +1 +17%
CCMH
44
Cornerstone Capital Management Holdings
New York
$31K
State Street
45
State Street
Massachusetts
$30K
Stifel Financial
46
Stifel Financial
Missouri
$24K -$9.78K -2 -29%
Citigroup
47
Citigroup
New York
$24K
BJ
48
BlackRock Japan
Japan
$23K -$4.89K -1 -20%
TH
49
Timber Hill
Connecticut
$23K
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$15K

ACHV Hedge Fund Activity: Q4 2014 in Review

56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2014, worth a combined $20.3M — down 16% from $24.1M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new ACHV positions and 6 closed out — a net gain of 5 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was BVF Inc, adding an estimated $1.57M. The largest seller was Great Point Partners, exiting entirely with an estimated $4.79M sold.

  • 56 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $20.3M of Achieve Life Sciences stock for Q4 2014, down 16% quarter-over-quarter.
  • 11 funds opened new Achieve Life Sciences positions in Q4 2014 and 6 closed out, a net change of +5 holders.
  • The largest Achieve Life Sciences buyer in Q4 2014 was BVF Inc, an estimated $1.57M added.
  • The largest Achieve Life Sciences seller in Q4 2014 was Great Point Partners, an estimated $4.79M sold.

Based on aggregated 13F filings for Q4 2014.